Careful consideration when responding to new data: dolutegravir and pregnancy

A Careful Consideration of the Calibration Concept

This paper presents a detailed discussion of the technical aspects of the calibration process with emphasis on the definition of the measurand, the conditions under which the calibration results are valid, and the subsequent use of the calibration results in measurement uncertainty statements. The concepts of measurement uncertainty, error, systematic error, and reproducibility are also address...

a new approach to credibility premium for zero-inflated poisson models for panel data

هدف اصلی از این تحقیق به دست آوردن و مقایسه حق بیمه باورمندی در مدل های شمارشی گزارش نشده برای داده های طولی می باشد. در این تحقیق حق بیمه های پبش گویی بر اساس توابع ضرر مربع خطا و نمایی محاسبه شده و با هم مقایسه می شود. تمایل به گرفتن پاداش و جایزه یکی از دلایل مهم برای گزارش ندادن تصادفات می باشد و افراد برای استفاده از تخفیف اغلب از گزارش تصادفات با هزینه پائین خودداری می کنند، در این تحقیق ...

new guidelines in management of thyroid nodule when to biopsy and when to follow

lack of unified system in characterizing and reporting thyroid nodules is deeply felt almost in every institution and is a source of confusion among diagnostic radiologists, pathologists, thyroid surgeons, oncologists, endocrinologists and interventionalists. elaborate systems exist but they are not easy to use. therefore many of those systems cannot be utilized widely in general radiology prac...

HIV–1 resistance to dolutegravir: update and new insights

Integrase strand transfer inhibitors (INSTIs) are the latest class of potent anti-HIV drugs. Currently, three INSTIs have been approved by the US Food and Drug Administration: raltegravir (RAL), elvitegravir (EVG) and dolutegravir (DTG). Resistance mutations to RAL and EVG emerge rapidly, and significant cross-resistance between these compounds has been documented. In addition, limited cross-re...

Dolutegravir monotherapy: when should clinical practice be clinical research?